Special Report
AnnJi Reports Promising Phase 1/2a Results for AJ201 in Rare Neuromuscular Disease SBMA
AnnJi Pharmaceutical Co., Ltd., a clinical-stage Taiwanese biotechnology company focused on addressing unmet medical needs in dermatology, neurology, and r...
May 22, 2025 | News
AstraZeneca’s AIRSUPRA Cuts Severe Asthma Exacerbations by 47%, Redefines Mild Asthma Treatment Standard
AIRSUPRA demonstrated a 47% reduction in the risk of severe exacerbations in mild asthma compared with albuterol alone Full results published in th...
May 20, 2025 | News
Nordic Bioscience Launches nordicEndotrophin™ to Advance Risk Stratification and Monitoring in Fibrosis and Cancer
Nordic Bioscience introduces nordicEndotrophin™, a fully automated high-precision assay that selectively quantifies the intact 77-amino-acid Endotrop...
May 19, 2025 | News
Shanghai Ark Biopharmaceutical Announces Positive Phase II Results for AK3280 in Idiopathic Pulmonary Fibrosis
Shanghai Ark Biopharmaceutical Co., Ltd. announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of id...
May 16, 2025 | News
Gene Solutions Validates K-TRACK™ ctDNA Test as Prognostic Biomarker
Gene Solutions, a biotechnology company dedicated to advancing precision oncology in Asia, is excited to announce the publication of a pioneering real-worl...
May 12, 2025 | News
Nutshell Therapeutics Receives FDA IND Clearance for First-in-Human Trial of NTS071 Targeting p53 Y220C Mutation
Nutshell Therapeutics ( Shanghai ) Co., LTD. received IND clearance from the FDA to initiate Phase 1 clinical ...
May 05, 2025 | News
Aroa Biosurgery Surpasses 100 Peer-Reviewed Studies Validating AROA ECM Technology in Wound Care
Soft tissue regeneration company, Aroa Biosurgery, is pleased to announce a milestone in clinical evidence. There are now over 100 peer-reviewed stud...
May 05, 2025 | Report
Genmab to Submit sBLA for Epcoritamab-R2 Combination in Relapsed/Refractory Follicular Lymphoma Following Positive Phase 3 Data
--Genmab A/S (Nasdaq: GMAB) announced its intention to submit in the first half of 2025 a supplemental Biologics License Application (sBLA) to t...
May 05, 2025 | Regulatory
Siemens Healthineers Launches MAMMOMAT B.brilliant to Advance Early Breast Cancer Detection in Indonesia
Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the...
May 02, 2025 | News
Genocury Biotech’s In Vivo CD19 CAR-T Achieves Complete Remission in R/R DLBCL Without Lymphodepletion
Genocury Biotech today revealed groundbreaking clinical data from its noval in vivo CD19 CAR-T therapy in relapsed/refractory diffuse large ...
May 01, 2025 | News
Innovent Biologics Secures NMPA Approval for Limertinib as First-Line Therapy for EGFR-Mutated NSCLC in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...
April 28, 2025 | News
Oligonucleotide Market Surges as RNA-Based Therapeutics and CDMO Investments Redefine Global Healthcare Strategies
The global oligonucleotide market, once considered niche, has emerged as a pivotal segment in advanced therapeutics and innovative manufacturing strategies...
April 24, 2025 | Analysis
Roche Survey Calls for Immediate Action as Asia Pacific Faces Worsening Vision Health Crisis
Asia Pacific bears nearly two-thirds of the global burden of moderate-to-severe vision impairment. Although 90 percent of vision impairment is preventable ...
April 24, 2025 | News
Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
Cell therapy stands at the forefront of modern medicine, offering transformative potential for treating a wide spectrum of diseas...
April 22, 2025 | Report
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
